Global support for a quality solution

We lead innovation in peptide API’s to the benefit of millions of patients

Contact us

Market leader in peptide API manufacturing and services

PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API). 

Business news

FluoGuide reaches milestone with FG001 for phase III clinical supply

9 Nov 2022 - Copenhagen, Denmark, 8 November 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to inform that the first large scale batch for its lead product […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide with encouraging progress within custom projects pipeline – however with lower profitability in the first half of 2022

19 Aug 2022 - Baar, 19 August 2022 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligo-nucleotide-based active pharmaceutical ingredients, today announced its detailed results […]

Read more

PolyPeptide video

PolyPeptide Group - Ahead on green peptide chemistry


Where to meet us next